{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:53:35Z","timestamp":1790553215422,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/iae.0000000000001303","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T04:19:19Z","timestamp":1473826759000},"page":"1084-1091","source":"Crossref","is-referenced-by-count":56,"title":["MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY"],"prefix":"10.1097","volume":"37","author":[{"given":"R\u00f3bert","family":"Gergely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ill\u00e9s","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"R\u00e9cs\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n Zsolt","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nika","family":"Ecsedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":"The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"key":"R2-10-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R3-10-20210130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R4-10-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","article-title":"Diagnosis and interventions for central serous chorioretinopathy: review and update","volume":"41","author":"Quin","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R5-10-20210130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0b013e3283459826","article-title":"Review and update of central serous chorioretinopathy","volume":"22","author":"Ross","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"R6-10-20210130","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"R7-10-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"R8-10-20210130","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"R9-10-20210130","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajo.2011.04.008","article-title":"A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy","volume":"152","author":"Bae","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R10-10-20210130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bjo.2010.182121","article-title":"Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy","volume":"95","author":"Lim","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R11-10-20210130","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/FTD.0b013e31820beb02","article-title":"Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial","volume":"31","author":"Wu","year":"2011","journal-title":"Retina"},{"key":"R12-10-20210130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","article-title":"Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study","volume":"23","author":"Yannuzzi","year":"2003","journal-title":"Retina"},{"key":"R13-10-20210130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/02713680903428306","article-title":"Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study","volume":"35","author":"Artunay","year":"2010","journal-title":"Curr Eye Res"},{"key":"R14-10-20210130","first-page":"2145","article-title":"Intravitreal bevacizumab injection for chronic central serous chorioretinopathy","volume":"123","author":"Li","year":"2010","journal-title":"Chin Med J (Engl"},{"key":"R15-10-20210130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00417-010-1581-9","article-title":"The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy","volume":"249","author":"Lim","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-10-20210130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IAE.0b013e3181bcf0b4","article-title":"Intravitreal bevacizumab injection for central serous chorioretinopathy","volume":"30","author":"Lim","year":"2010","journal-title":"Retina"},{"key":"R17-10-20210130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3928\/23258160-20131220-01","article-title":"Current concepts in managing central serous chorioretinopathy","volume":"45","author":"Fine","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R18-10-20210130","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.ophtha.2012.02.021","article-title":"Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy","volume":"119","author":"Jirarattanasopa","year":"2012","journal-title":"Ophthalmology"},{"key":"R19-10-20210130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"R20-10-20210130","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"R21-10-20210130","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J"},{"key":"R22-10-20210130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11906-013-0414-8","article-title":"Converging indications of aldosterone antagonists (spironolactone and eplerenone): a narrative review of safety profiles","volume":"16","author":"Danjuma","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"R23-10-20210130","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"R24-10-20210130","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00417-014-2780-6","article-title":"Spironolactone in the treatment of central serous chorioretinopathy\u2014a case series","volume":"252","author":"Herold","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-10-20210130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/IAE.0000000000000748","article-title":"Central serous chorioretinopathy treated with mineralocorticoid antagonists: a one-year pilot study","volume":"36","author":"Ghadiali","year":"2016","journal-title":"Retina"},{"key":"R26-10-20210130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11906-013-0414-8","article-title":"Converging indications of aldosterone antagonists (spironolactone and eplerenone): a narrative review of safety profiles","volume":"16","author":"Danjuma","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"R27-10-20210130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R28-10-20210130","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ophtha.2008.01.021","article-title":"Morphologic changes in acute central serous chorioretinopathy evaluated by Fourier-domain optical coherence tomography","volume":"115","author":"Fujimoto","year":"2008","journal-title":"Ophthalmology"},{"key":"R29-10-20210130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10384-009-0766-4","article-title":"Restoration of outer segments of foveal photoreceptors after resolution of central serous chorioretinopathy","volume":"54","author":"Ojima","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"R30-10-20210130","first-page":"484","article-title":"Standardization of choroidal thickness measurements using enhanced depth imaging optical coherence tomography","volume":"8","author":"Boonarpha","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"R31-10-20210130","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1167\/iovs.10-6811","article-title":"Reproducibility of retinal and choroidal thickness measurements in enhanced depth imaging and high-penetration optical coherence tomography","volume":"52","author":"Ikuno","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000001303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:17:53Z","timestamp":1620940673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201706000-00010"}},"subtitle":["A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001303","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}